Review: Cannabinoids as Medicinals.

Jag H KhalsaGregory BuntKenneth BlumSanjay B MaggirwarMarc GalanterMarc N Potenza

Published in: Current addiction reports (2022)

to treat multiple clinical conditions, but more preclinical, and clinical studies and clinical trials, which follow regulatory guidelines, are needed to formally recommend CBD and other cannabinoids as medicines.

Keyphrases

clinical trial
clinical practice
cell therapy
phase ii
randomized controlled trial
open label
mesenchymal stem cells
study protocol
phase iii